Nomura
-
Drug manufacturer Alkem Laboratories has set the price range for its Rp13.5bn ($202m) IPO in India, with the offering set to launch on December 8.
-
Albaraka Turk Katilim Bankasi (Albaraka Turk) priced Turkey’s first Basel III compliant tier two sukuk deal in line with guidance on Monday.
-
Coopération Pharmaceutique Française, the French pharmaceuticals distributor known as Cooper, has bank meetings scheduled on Wednesday for more than €350m of new debt for its leveraged buyout by Charterhouse.
-
Logan Property Holdings Co raised HK$1.55bn ($200m) from a top-up placement on November 25, which was well received despite investors’ lack of familiarity with the company.
-
Swedbank bucked a trend of issuers turning to covered bonds for funding on Thursday when it launched a five year fixed rate senior deal.
-
Logan Property Holdings Co raised HK$1.55bn ($200m) from a top-up placement on November 25, pulling off a successful trade despite the huge chunk of shares on sale and investors’ lack of familiarity with the company.
-
A careful build up helped Veneto Banca raise €200m in tier two debt on Tuesday, as the bank looks to improve its capital position ahead of a share sale in 2016.
-
Albaraka Turk Katilim Bankasi (Albaraka Turk) priced Turkey’s first Basel III compliant tier two sukuk deal in line with guidance on Monday.
-
Coopération Pharmaceutique Française, the French pharmaceuticals distributor known as Cooper, has bank meetings scheduled on Wednesday for more than €350m of new debt for its leveraged buyout by Charterhouse.
-
Royal Bank of Scotland has hired a well known high yield specialist to head corporate and event driven credit trading.
-
Avago Technologies, the US semiconductor components maker, has increased the €500m tranche of its term loan ‘B’ to €900m on strong demand, in another sign of the European leveraged loan market’s competitiveness.
-
Allied Irish Banks was in a generous mood on Thursday, launching its first tier two since the crisis at a much higher premium than rival bankers thought necessary.